Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

REINFORCE

Financiado

Cerrado

Inflammatory Bowel Disease an EU NZ integrated approach for characterizing its...

Inflammatory Bowel Disease an EU NZ integrated approach for characterizing its molecular multifactorial mechanisms Over the past 20 years there has been a dramatic rise in the incidence of Inflammatory bowel disease (IBD), both in EU and NZ. IBD refers primarily to two major disorders such as ulcerative colitis (UC) and Crohn's disease (CD), c... ver más

31/12/2014

UNIBO

536K€

Presupuesto del proyecto: 536K€

Líder del proyecto

ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-12-31 No tenemos la información de la convocatoria

0% 64% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

UNIBO

0.00€ | Lider

UEA

N.D. | Participante

ICS

N.D. | Participante

MUI

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

IMMUNOBIOME Identifying microbiotal triggers of inflammatory bowel disea... 2M€ Cerrado

MITI 2 Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease... 6M€ Cerrado

IBD-CHARACTER Inflammatory Bowel Disease CHARACTERization by a multi modal... 8M€ Cerrado

MUCO-IMMUN MUCOBIOME MEDIATED IMMUNE PATHWAYS IN INFLAMMATORY BOWEL DIS... 166K€ Cerrado

FLAMINCO Therapeutic discovery for Inflammatory Bowel Disease 150K€ Cerrado

GUT TC PHENOTYPES Regulation of Pathogenic CD4 T Cell Responses in Inflammator... 231K€ Cerrado

Líder del proyecto

ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 536K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Over the past 20 years there has been a dramatic rise in the incidence of Inflammatory bowel disease (IBD), both in EU and NZ. IBD refers primarily to two major disorders such as ulcerative colitis (UC) and Crohn's disease (CD), chronic conditions characterized by inflammatory lesions involving gut mucosa. CD is also an emerging problem amongst children. Etiology of IBD is still unknown, however several studies demonstrate multifactorial mechanisms contributing to its pathogenesis (i.e. immunoregulatory defects, genetic mutations, dysbiosis of commensal enteric microbiota, alterations in mucosal permeability, alimentary factors). The complexity of these factors makes necessary for a researcher to acquire the widest spectrum of advanced techniques enabling the deeper understanding of IBD onset and recurrence and developing useful therapeutic strategies. Both Eu and NZ have significantly contribute to IBD research advances, by developing outstanding research expertise and being equipped with the most advance methodological tools. REINFORCE consortium is a multidisciplinary scientific network, in which each partner is a leader in IBD mechanisms. The high level of synergies within REINFORCE consortium, highlighting the cross-talk among different disciplines, will provide a multidisciplinary training for EU and NZ researchers. This joint exchange programme represents a unique opportunity to lead to a high degree of novelty in IBD training by allowing to build up a new profile of researcher able to tackle the different aspects of IBD. REINFORCE has settled down a series of specific and technical objectives which will guarantee the ESRs and ERs to be provided with training tools ensuring the use of the most advanced molecular and cellular techniques. Training modules will concern: (i) IBD Modulation of Immune response, (ii) IBD Characterization and modulation of gut microbiota, (iii) IBD intestinal epithelial barrier, (iv) Nutrition and genetics on IBD.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores